文献速递皮肤肿瘤

针对高复发风险黑色素瘤患者癌症复发恐惧的简短心理干预:随机对照试验12个月随访结果

Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial.
PubMed 文献 · Br J Dermatol · 2019-07-25

本研究为两臂随机对照试验,纳入既往诊断为0、I或II期黑色素瘤的成人,干预组80例接受76页心理教育资料及三次电话心理辅导,对照组84例接受常规护理。

要点

  • 简短心理干预可显著降低高复发风险黑色素瘤患者的癌症复发恐惧严重度。
  • 干预对复发恐惧触发因素亦有显著改善,且未见已知不良效应。
  • 焦虑、抑郁及健康相关生活质量等次要结局无组间差异。

核心结论

  • 针对癌症复发恐惧的简短心理干预在12个月随访时仍显示优于常规护理的持续获益。

研究设计与样本

  • 两臂随机对照试验,干预组80例、对照组84例,均为既往诊断为0、I或II期黑色素瘤的成人。
  • 干预包括76页心理教育资料及三次由心理学家提供的个体化电话辅导,安排在皮肤科就诊前后特定时间点。
  • 主要结局为干预后12个月采用癌症复发恐惧量表严重度亚量表评估的自我报告恐惧水平。

主要发现

  • 焦虑、抑郁及健康相关生活质量等次要结局无组间差异。

临床怎么用

  • 该简短心理干预可考虑作为黑色素瘤常规护理的一部分实施,以持续降低癌症复发恐惧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with melanoma want and need effective interventions for living with fear of cancer recurrence (FCR). OBJECTIVES: This study reports the 12-month outcomes of a brief, psychological intervention designed to reduce FCR in people at high risk of developing another primary melanoma compared with usual care. METHODS: In this two-arm randomized controlled trial, adults previously diagnosed with stage 0, I or II melanoma were randomly allocated to the intervention (n = 80) or control (usual care) arm (n = 84). The trial was registered with the Australian and New Zealand Clinical Trials Registry on 19 March 2013 (registration: ACTRN12613000304730). The intervention comprised a 76-page psychoeducational resource and three individually tailored, telephone-based sessions with a psychologist, scheduled at specific time points around participants' dermatological appointments. The primary outcome was the level of self-reported fear of new or recurrent melanoma assessed at 12 months postintervention using the severity subscale of the Fear of Cancer Recurrence Inventory. RESULTS: Compared with the control arm, the intervention group reported significantly lower FCR at 12 months postintervention; the between-group mean difference was -1·41 for FCR severity [95% confidence interval (CI) -2·6 to -0·2; P = 0·02] and -1·32 for FCR triggers (95% CI -2·6 to -0·02; P = 0·04). The odds ratio for FCR severity scores ≥13 (54% intervention, 63% control) was 0·59 (95% CI 0·30-1·14, P = 0·12). There were no differences between groups in secondary outcomes, such as anxiety, depression or health-related quality of life. CONCLUSIONS: The previously reported 6-month benefits of this brief, patient-centred psychological intervention in reducing FCR were found to continue 12 months postintervention, with no known adverse effects, supporting implementation as part of routine melanoma care.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Dieng M, Morton RL, Costa DSJ, et al. Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial. Br J Dermatol. 2019. PMID: 30965384. doi:10.1111/bjd.17990

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。